{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T11:59:00Z","timestamp":1791115140339,"version":"4.1.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2003,9,1]],"date-time":"2003-09-01T00:00:00Z","timestamp":1062374400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathol. Oncol. Res."],"published-print":{"date-parts":[[2003,9]]},"DOI":"10.1007\/bf03033732","type":"journal-article","created":{"date-parts":[[2009,9,27]],"date-time":"2009-09-27T19:39:55Z","timestamp":1254080395000},"page":"170-173","source":"Crossref","is-referenced-by-count":20,"title":["Increased expression of vascular endothelial growth factor (VEGF) in bone marrow of patients with myeloproliferative disorders (MPD)"],"prefix":"10.1007","volume":"9","author":[{"given":"Tomasz","family":"Wr\u00f3bel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grzegorz","family":"Mazur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawe","family":"Surowiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dariusz","family":"Wolowiec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Jelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazimierz","family":"Kuliczkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BF03033732_CR1","first-page":"496","volume":"110","author":"FM Belgore","year":"2000","unstructured":"Belgore FM, Lip G, Bareford D, et al: Plasma levels of vascular endothelial growth factor (VEGF) in haematological cancers. Br J Haematol 110: 496\u2013497, 2000.","journal-title":"Br J Haematol"},{"key":"BF03033732_CR2","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1046\/j.1365-2141.2002.03443.x","volume":"117","author":"MA Elliot","year":"2002","unstructured":"Elliot MA, Mesa RA, Li CY, et al: Thalidomide treatment in myelofibrosis with myeloid metaplasia. Br J Haematol 117: 288\u2013296, 2002.","journal-title":"Br J Haematol"},{"key":"BF03033732_CR3","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1056\/NEJM199907153410306","volume":"341","author":"S Faderl","year":"1999","unstructured":"Faderl S, Talpaz M, Estrov Z, et al: The biology of chronic myeloid leukemia. N Engl J Med 341: 164\u2013172, 1999.","journal-title":"N Engl J Med"},{"key":"BF03033732_CR4","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/nm0195-27","volume":"1","author":"J Folkman","year":"1995","unstructured":"Folkman J: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1: 27\u201331, 1995.","journal-title":"Nat Med"},{"key":"BF03033732_CR5","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1177\/29.4.6166661","volume":"29","author":"SM Hsu","year":"1981","unstructured":"Hsu SM, Raine L, Fanger H: Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29: 577\u2013582, 1981.","journal-title":"J Histochem Cytochem"},{"key":"BF03033732_CR6","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/sj.leu.2402486","volume":"16","author":"A Janowska-Wieczorek","year":"2002","unstructured":"Janowska-Wieczorek A, Majka M, Marquez-Curtis L, et al: Bcr-abl-positive cells secrete angiogenic factors including matrix metalloproteinases and stimulate angiogenesis in vivo in Martigel implants. Leukemia 16: 1160\u20131166, 2002.","journal-title":"Leukemia"},{"issue":"II","key":"BF03033732_CR7","first-page":"6","volume":"76","author":"CY Li","year":"2002","unstructured":"Li CY: The role of morphology, cytochemistry and immunochemistry in the diagnosis of chronic myeloproliferative diseases. Int J Haematol 76, (Suppl II): 6\u20138, 2002.","journal-title":"Int J Haematol"},{"key":"BF03033732_CR8","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0002-9440(10)64511-7","volume":"157","author":"LG Lundberg","year":"2000","unstructured":"Lundberg LG, Lerner R, Sundelin P, et al: Bone marrow in polycythemia vera, chronic myeloid leukemia and myelofibrosis has an increased vascularity. Am J Pathol 157: 15\u201319, 2000.","journal-title":"Am J Pathol"},{"key":"BF03033732_CR9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1634\/theoncologist.5-suppl_1-3","volume":"5","author":"G McMahon","year":"2000","unstructured":"McMahon G: VEGF receptor signaling in tumor angiogenesis. Oncologist 5: 3\u201310, 2000.","journal-title":"Oncologist"},{"key":"BF03033732_CR10","first-page":"771","volume":"86","author":"S Molica","year":"2001","unstructured":"Molica S, Santoro R, Iuliano F, et al: Serum levels of vascular endothelial growth factor in chronic leukemias. A comparative study with emphasis on myeloproliferative disorders. Hematologica 86:771, 2001.","journal-title":"Hematologica"},{"key":"BF03033732_CR11","first-page":"29","volume":"34","author":"S Murphy","year":"1997","unstructured":"Murphy S, Peterson P, Hand H, et al: Experience of the Polycytaemia Vera Study Group with essential thrombocytaemia: A final report on diagnostic criteria, survival and leukemic transition by treatment. Semin Hematol 34: 29\u201335, 1997.","journal-title":"Semin Hematol"},{"key":"BF03033732_CR12","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/ajh.10020","volume":"69","author":"C Musolino","year":"2002","unstructured":"Musolino C, Calabro L, Bellomo G, et al: Soluble angiogenic factors: implications for chronic myeloproliferative disorders. Am J Hemat 69: 159\u2013163, 2002.","journal-title":"Am J Hemat"},{"issue":"1","key":"BF03033732_CR13","first-page":"87","volume":"22","author":"TC Pearson","year":"1996","unstructured":"Pearson TC, Messinezy M: The diagnostic criteria of polycythemia rubra vera. Leuk Lymphoma 22, (suppl1): 87\u201394, 1996.","journal-title":"Leuk Lymphoma"},{"key":"BF03033732_CR14","first-page":"815","volume":"150","author":"AR Perez-Atayde","year":"1997","unstructured":"Perez-Atayde AR, Sallan SE, Tedrow U, et al: Spectrum of tumor angiogenesis in bone marrow of children with acute lymphoblastic leukemia. Am J Pathol 150: 815\u2013821, 1997.","journal-title":"Am J Pathol"},{"key":"BF03033732_CR15","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1159\/000046614","volume":"106","author":"F Raimondo Di","year":"2001","unstructured":"Di Raimondo F, Palumbo G, Molica S, et al: Angiogenesis in chronic myeloproliferative diseases. Acta Haematol 106: 177\u2013183, 2001.","journal-title":"Acta Haematol"},{"key":"BF03033732_CR16","first-page":"138","volume":"8","author":"W Remmele","year":"1987","unstructured":"Remmele W, Stenger HE: Vorschlag zur einheitlichen Definition eines Immunreaktiven Score (IRS) fuer den immunohistochemischen Oestrogenrezeptor Nachweis (ER-ICA) im Mammakarzinomgewebe. Pathologe 8: 138\u2013140, 1987.","journal-title":"Pathologe"},{"key":"BF03033732_CR17","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1177\/39.6.1709656","volume":"39","author":"SR Shi","year":"1991","unstructured":"Shi SR, Key ME, Kalra KL: Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microvave oven heating of tissue sections. J Histochem Cytochem 39: 741\u2013746, 1991.","journal-title":"J Histochem Cytochem"},{"key":"BF03033732_CR18","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.4065\/73.12.1177","volume":"73","author":"A Tefferi","year":"1998","unstructured":"Tefferi A: The Philadelphia chromosome negative chronic myeloproliferative disorders: A practical overview. Mayo Clin Proc 73: 1177\u20131184, 1998.","journal-title":"Mayo Clin Proc"},{"key":"BF03033732_CR19","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1159\/000046616","volume":"106","author":"DA Thomas","year":"2001","unstructured":"Thomas DA, Giles FJ, Cortes J, et al: Antiangiogenic therapy in leukemia. Acta Haematol 106: 190\u2013207, 2001.","journal-title":"Acta Haematol"},{"key":"BF03033732_CR20","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0953-6205(03)00027-X","volume":"14","author":"T Wr\u00f3bel","year":"2003","unstructured":"Wr\u00f3bel T, Mazur G, Surowiak P, et al: Increased expression of vascular endothelial growth factor (VEGF) in bone marrow of multiple myeloma (MM) patients. Eur J Internal Med 14: 98\u2013100, 2003.","journal-title":"Eur J Internal Med"},{"key":"BF03033732_CR21","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1182\/blood.V99.6.2265","volume":"99","author":"S Verstovsek","year":"2002","unstructured":"Verstovsek S, Kantarijan H, Manshourti T, et al: Prognostic significance of cellular vascular endothelial growth factor expression in chronic phase chronic myeloid leukemia. Blood 99: 2265\u20132267, 2002.","journal-title":"Blood"}],"container-title":["Pathology & Oncology Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03033732.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03033732\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03033732","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T00:44:48Z","timestamp":1558572288000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03033732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,9]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2003,9]]}},"alternative-id":["BF03033732"],"URL":"https:\/\/doi.org\/10.1007\/bf03033732","relation":{},"ISSN":["1219-4956"],"issn-type":[{"value":"1219-4956","type":"print"}],"subject":[],"published":{"date-parts":[[2003,9]]}}}